Park Medi World Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Park Medi World Ltd is ₹ 215.5 as of 23 Oct 15:30 . The P/E Ratio of Park Medi World Ltd changed from 31.7 on March 2026 to 31.7 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Park Medi World Ltd changed from ₹ 8191 crore on March 2026 to ₹ 8191 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Park Medi World Ltd for the Jun '26 is ₹ 483.36 crore as compare to the Mar '26 revenue of ₹ 467.92 crore. This represent the growth of 3.3% The revenue of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Park Medi World Ltd for the Jun '26 is ₹ 133.73 crore as compare to the Mar '26 ebitda of ₹ 134.87 crore. This represent the decline of -0.85% The ebitda of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Park Medi World Ltd changed from ₹ 45.65 crore to ₹ 88.59 crore over 7 quarters. This represents a CAGR of 46.06% The net profit of Vanta Bioscience Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Park Medi World Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Park Medi World Ltd

Park Medi World Quarterly Result Overview Park Medi World quarterly results present a clear summary of financial performance across different reporting periods.
Investors can review revenue, profit, and overall business trends without studying detailed financial statements. Park Medi World quarterly results date helps track when each financial update is released during the year.
The overview shows how the company performs under changing business conditions and the market environment. Key Metrics of Park Medi World Quarterly Result Here are the main metrics typically covered: 1.
Revenue Revenue shows the total income generated from business activities during the reporting period.
Performance changes in quarterly results, such as Park Medi World Q3 results, may reflect seasonal demand and business cycles. 2.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Park Medi World Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Park Medi World Ltd or Vanta Bioscience Ltd?

Market cap of Park Medi World Ltd is 9,308 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Park Medi World Ltd and Vanta Bioscience Ltd?

The stock performance of Park Medi World Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Park Medi World Ltd and Vanta Bioscience Ltd?

As of October 25, 2026, the Park Medi World Ltd stock price is INR ₹215.5. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Park Medi World Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Park Medi World Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.